Báo cáo khoa học: Mitochondria regulate platelet metamorphosis induced by opsonized zymosan A – activation and long-term commitment to cell death docx

Mitochondria regulate platelet metamorphosis induced by opsonized zymosan A – activation and long-term commitment to cell death Paola Matarrese1, Elisabetta Straface1, Giuseppe Palumbo2, Maurizio Anselmi2, Lucrezia Gambardella1, Barbara Ascione1, Domenico Del Principe2 and Walter Malorni1 Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanita’, Rome, Italy Department of Pediatrics, University of Rome Tor Vergata, Italy Keywords aggregation; apoptosis; mitochondrial membrane potential; platelets; zymosan Correspondence P Matarrese, Department of Therapeutic Research and Medicines Evaluation, Section of Cell Aging and Degeneration, Istituto Superiore di Sanita’, viale Regina Elena 299, 00161 Rome, Italy Fax: +39 49903691 Tel: +39 49902010 E-mail: paola.matarrese@iss.it (Received November 2008, revised 25 November 2008, accepted December 2008) doi:10.1111/j.1742-4658.2008.06829.x Changes in the mitochondrial membrane potential play a key role in determining cell fate Mitochondria membrane hyperpolarization has been found to occur after cell activation, e.g in lymphocytes, whereas depolarization is associated with apoptosis The aim of this study was to investigate the effects of an immunological stimulus, i.e opsonized zymosan A, on human platelet mitochondria by means of flow and static cytometry analyses as well as biochemical methods We found that opsonized zymosan induced significant changes of platelet morphology at early time points (90 min) This was associated with increased production of reactive oxygen species, and, intriguingly, mitochondrial membrane hyperpolarization At a later time point (24 h), opsonized zymosan was found to induce increased expression of CD47 adhesion molecule, platelet aggregation, mitochondrial membrane depolarization and phosphatidylserine externalization Although these late events usually represent signs of apoptosis in nucleated cells, in opsonized zymosan-treated platelets they were not associated with membrane integrity loss, changes in Bcl-2 family protein expression or caspase activation In addition, pre-treatment with low doses of the ‘mitochondriotropic’ protonophore carbonyl cyanide p-(trifluoro-methoxy)phenylhydrazone counteracted mitochondrial membrane potential alterations, production of reactive oxygen species and phosphatidylserine externalization induced by opsonized zymosan Our data suggest that mitochondrial hyperpolarization represents a key event in platelet activation and remodeling under opsonized zymosan immunological stimulation, and opsonized zymosan immunological stimulation may represent a useful tool for understanding of the pathogenetic role of platelet alterations associated with vascular complications occurring in metabolic and autoimmune diseases Several mechanisms are brought into play in order to control the balance between platelet production and destruction Among these, recent studies have identified a form of apoptosis Platelets have been shown to be able to undergo apoptosis in response to various stimuli [1,2] It has been reported that platelet differentiation recapitulates morpho-functional events that are typical of apoptosis, such as trans-bilayer migration of phosphatidylserine (PS) to the outer membrane leaflet [3] Platelets also express Abbreviations AM, acetoxymethyl ester; DHR123, dihydrorhodamine 123; DIC, differential interference contrast; FCCP, carbonyl cyanide p-(trifluoro-methoxy) phenylhydrazone; IVM, intensified video microscopy; JC-1, 5-5¢,6-6¢-tetrachloro-1,1¢,3,3¢-tetraethylbenzimidazol-carbocyanine iodide; MMP, mitochondrial membrane potential; OPZ, opsonized zymosan; PRP, platelet-rich plasma; PS, phosphatidylserine; ROS, reactive oxygen species FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS 845 Mitochondria in platelet activation P Matarrese et al many components of nucleated-cell apoptosis such as caspases [1,4] Mitochondria are generally considered to be key players in cell life and death In addition to energy supply, they have also been demonstrated to be involved in execution of apoptosis via the release of apoptogenic factors such as cytochrome c [5] Human blood platelet mitochondria play a critical role as they work efficiently as energy factories for both resting and stimulated cells Mitochondria are also involved in non-ATP-related functions such as oxygen radical generation and apoptotic-like events In fact, mitochondrial damage has been reported to be a key step in platelet apoptosis, and mitochondrial membrane potential (MMP) is lost during storage and under other conditions [4,6,7] Changes in the mitochondrial permeability transition pore have been hypothesized to play a role in production of so-called coated platelets, a sub-population of platelets observed upon dualagonist activation, e.g thrombin plus collagen, that express surface PS and can be induced by activation of the pro-apoptotic Bcl-2 family member Bax [3] Hence, mitochondria integrity and function appear to act as general regulators of platelet fate in terms of both activation and apoptosis, two processes that, in platelets, appear to share some common features, e.g PS externalization Zymosan A, a complex polysaccharide obtained from Saccharomyces cerevisiae, is a complement activator that can be used as a tool to investigate the role of activated platelets in several diseases, including immune complex-mediated inflammation and its vascular complications [8] Once opsonized, zymosan A has been suggested to activate platelets in a complementand fibrinogen-dependent way In particular, complement components, such as C5, C6 and C7, are necessary, and IgG binding is also required for zymosan opsonization [9,10] Hence, opsonized zymosan (OPZ) could represent a suitable model for the study of platelets as ‘inflammatory’ cells In view of this, we decided to investigate whether this immunological stimulus may induce mitochondria dysfunction and influence platelet fate We found that mitochondria modifications have a dual role, controlling both platelet activation and death Results Characterization of morphological modifications induced by OPZ Treatment with OPZ induced two main modifications of platelet morphology: (a) cell remodeling typical of activation at early time points (after 30 and, more markedly, 90 min), and (b) platelet aggregation after 24 h With regard to cell remodeling, we decided to analyze the actin cytoskeleton organization This appeared to be significantly modified by OPZ (Fig 1A): redistribution of actin filaments, forming long actin-positive protrusions (arrows), was detected in platelets exposed for 90 to zymosan (central panel), and, more especially, to OPZ (right panel) Scanning electron microscopy analysis indicated that exposure to OPZ for 30 (not shown) and 90 (Fig 1B) appeared to activate platelets: the typical round morphology of platelets was altered to an activated morphology characterized by emission of thin protrusions A series of analyses were also performed using CD47, the thrombospondin receptor, a surface molecule involved in cell adhesion [11] Flow cytometry analyses revealed no changes at early time points, but platelet alterations were observed 24 h after OPZ administration A platelet sub-population overexpressing CD47 was detected in zymosan-treated, and especially OPZ-treated, platelets (a representative flow cytometry analysis is shown in Fig 1C) This increased expression was also detected by immunofluorescence analysis, and platelet aggregates were detectable after both zymosan and OPZ treatments (Fig 1D) The number of aggregates was Fig Characterization of platelet modifications induced by OPZ (A, B) Morphological alterations (A) IVM analysis of actin microfilaments Actin-positive protrusions (arrows) are visible in treated platelets (90 min) Insets in the middle and right panels show bright-field micrographs that have been electronically inverted to highlight these thin protrusions (arrows) Magnification ·1500 (B) Scanning electron microscopy Exposure to zymosan A (opsonized and non-opsonized) for 90 changed round-shaped resting platelets (control, left panel) into activated platelets characterized by the emission of long thin protrusions Magnification ·4000 (C–F) CD47 expression and cell-aggregation analyses (C) Histograms representing flow cytometry evaluation of surface expression of the adhesion molecule CD47 are shown in the upper panels Numbers represent the percentage of highly positive platelets In the lower panels, dot plots of the physical parameters of the platelet population (one representative experiment) are shown (D) IVM analysis showing the intracellular distribution of CD47 molecule in zymosan-treated cells (central panel) and OPZ-treated cells (right panel) (E) DIC (Nomarski) micrographs showing cell aggregates in zymosan-treated platelets (central panel) and OPZ-treated platelets (right panel) in comparison with untreated platelets (left panel) In (D) and (E), arrows indicate platelet aggregates (F) Quantification of cell aggregation by morphometric analysis performed using DIC Values are means and SD of the results obtained in three independent experiments *P < 0.01 versus control platelets; °P < 0.01 versus zymosan-treated platelets 846 FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS P Matarrese et al Mitochondria in platelet activation A Zymosan 90 Opsonized zymosan 90 Zymosan 24 h Untreated Opsonized zymosan 24 h µm B Count 200 200 Untreated 200 µm 2.3 100 101 102 103 104 24.7 0 14.2 100 101 102 103 104 100 101 102 103 104 SSC-Height 1000 SSC-Height 1000 FSC-Height 1000 0 C SSC-Height 1000 Fluorescence FSC-Height 1000 FSC-Height 1000 D 10 µm E µm F *° ° Aggregates (number/field) 20 15 * 10 Untreated Zymosan Opsonized zymosan FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS 847 Mitochondria in platelet activation P Matarrese et al evaluated The results of morphometric analysis by fluorescence microscopy (CD47-stained samples) and differential interference contrast (DIC, i.e Nomarski microscopy, Fig 1E,F) clearly indicated that the number of aggregates, which was negligible in control samples, was significantly increased in OPZ-treated samples in comparison with non-opsonized zymosan-treated cells (Fig 1F) OPZ-induced MMP alterations On the basis of previous studies, which reported increased MMP (hyperpolarization) in conjunction with cell activation, e.g in lymphocytes [12,13], and MMP loss (depolarization) in conjunction with apoptosis [5], we analyzed this parameter in platelets treated with opsonized and non-opsonized zymosan A at various time points Quantitative flow cytometry analysis, performed using a JC-1 probe (a representative experiment is shown in Fig 2A), clearly indicated the presence of a significantly higher percentage of cells with hyperpolarized mitochondria (see boxed areas) after treatment with OPZ (third row) in comparison with either untreated platelets (first row) or platelets treated with non-opsonized zymosan (second row) Importantly, this hyperpolarization of mitochondrial membrane started early after OPZ addition (second column) and peaked after 90 (third column) Interestingly, 24 h after OPZ addition (third row, fourth column), flow cytometry analysis clearly revealed a significant percentage of cells (approximately 35%) displaying mitochondrial membrane depolarization These effects were also evident by pooling together data obtained from four independent experiments: Fig 2B,C shows the percentage of cells with hyperpolarized or depolarized mitochondria, respectively Altogether, these results indicate that mitochondria of platelets treated with OPZ underwent a marked increase in MMP at early time points (until 90 min), followed by a significant MMP loss at later time points (starting from 24 h) Importantly, in our experimental system, the decrease in MMP was not paralleled by an alteration of Bax (Fig 2D) or Bak (Fig 2E) expression levels OPZ-induced ROS production Mitochondrial hyperpolarization has been related to hyperproduction of reactive oxygen species (ROS) [13,14] A quantitative time-course analysis of ROS generation during zymosan A treatment was thus performed using flow cytometry In accordance with the MMP data, increased ROS production was detected in OPZ-treated platelets using dihydrorhodamine 123 (DHR123) A representative experiment is shown in Fig 3A [compare control platelets (left) and non-opsonized zymosan-treated platelets (middle panel) with OPZ-treated platelets (right)] The results obtained from four independent experiments are reported in Fig 3B In OPZ-treated cells, increased ROS production was detectable at earlier time points (30 and 90 min), but the values detected after 24 h were similar to those found in control samples OPZ induces PS externalization (but not caspase activation) We analyzed PS externalization in platelets under various experimental conditions Flow cytometry evaluation of cell-surface expression of PS was performed using annexin V ⁄ trypan blue double staining Figure 4A shows the results of a representative experiment, and Fig 4B shows mean values obtained from four independent experiments These analyses clearly indicated that, in the absence of any stimulus, platelets displayed very low levels of PS at their surface up to 24 h after isolation (first row, bottom right quadrant), and non-opsonized zymosan treatment induced a small increase of the percentage of annexin V-positive cells (second row), whereas a time-dependent increase in PS externalization was observed in OPZ-treated cells (third row, bottom right quadrant) Interestingly, neither non-opsonized nor OPZ-treated platelets were positive for trypan blue dye (see percentages in the upper right quadrant), indicating that the plasma membrane of most cells was undamaged at least up to 24 h (Fig 4A, third row, fourth column) and 48 h (not shown) after OPZ administration These results were clearer when data obtained from four independent experiments were Fig OPZ induces MMP alterations (A) Biparametric flow cytometry analysis of MMP after staining with JC-1 in untreated platelets (first row), platelets treated with zymosan A (second row) and platelets treated with OPZ (third row) at various time points The numbers in the boxed areas represent the percentages of cells with hyperpolarized mitochondria The percentages of cells with depolarized mitochondria are shown below the dashed line The results obtained in a representative experiment are shown (B, C) Mean percentage (and SD) of platelets with hyperpolarized (B) or depolarized (C) mitochondria obtained from four cytofluorimetric experiments Statistical analyses indicate a significant (P < 0.01) increase in cells with hyperpolarized or depolarized mitochondria at early (up to 90 min) and late (24 h) time points, respectively, only in platelets challenged with OPZ (D, E) Bax (D) and Bak (E) expression levels as evaluated by FACS analysis The y axis shows the median values of fluorescence as the mean and SD from four independent experiments 848 FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS P Matarrese et al Mitochondria in platelet activation pooled (Fig 4B) Data on cell viability obtained by the trypan blue exclusion test were confirmed using calceinacetoxymethyl ester (AM) (Fig 4C) 10.4 9.7 T 24 h 104 T 90 104 T 30 104 T0 104 A On the basis of these results, analysis of the activation state of the main executioners of apoptosis, i.e caspases, was required We found that neither zymosan 11.1 10.6 7.1 100 104 11.5 100 104 104 14.9 12.2 100 104 100 7.1 100 104 104 104 104 100 5.6 100 100 Untreated 16.7 25.1 100 104 12.2 100 100 11.2 100 104 100 64.7 56.1 29.4 15.2 104 104 104 104 104 104 100 34.7 Opsonized zymosan 104 100 100 11.8 104 100 104 30.4 100 100 9.6 100 7.3 100 J-aggregates 100 6.9 100 Zymosan 100 104 J-monomers Untreated C 75 60 45 30 15 T0 T 30 T 90 Opsonized zymosan Zymosan T 24 h Cells with depolarized mitochondria (%) Cells with hyperpolarized mitochondria (%) B 40 30 20 10 Bak T 30 T 90 T 24 h Bax E Protein expression level (a.u.) Protein expression level (a.u.) D T0 T0 T 30 T 90 T 24 h FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS T0 T 30 T 90 T 24 h 849 Mitochondria in platelet activation P Matarrese et al T0 T 30 T 90 T 24 h A 200 Opsonized zymosan 200 Zymosan 200 Untreated M = 32.2 M = 44.2 M = 58.6 M = 22.5 100 101 102 103 104 M = 17.3 M = 21.4 M = 19.1 M = 22.7 Events M = 18.4 M = 20.3 M = 17.1 M = 31.6 100 101 102 103 104 100 101 102 103 104 Green fluorescence intensity B 70 Untreated * Zymosan ROS production (a.u.) 60 Opsonized zymosan * 50 40 30 20 10 T0 T 30 T 90 T 24 h Fig OPZ induces production of reactive oxygen species Quantitative cytofluorimetric analysis of ROS production was performed using DHR123 (A) Results obtained in a representative experiment The values represent the median fluorescence (B) Mean values (and SD) obtained from four independent experiments *P < 0.01 versus control and zymosan-treated cells (Fig 5A) nor OPZ (Fig 5B) induced activation of caspases and at any time point considered In particular, 90 after zymosan A administration, when we observed the maximum OPZ-induced MMP hyperpolarization (Fig 2) and ROS production (Fig 3), activation of caspase (which depends on the release of mitochondrial apoptogenic factors) [5] and caspase (the main enzyme involved in caspase-dependent apoptosis) was negligible Even if the zymosan A exposure time was prolonged to 24 h, at which time PS externalization and mitochondrial membrane depolarization were observed (see Fig 4), no significant activation of these caspases was detected As a positive control, platelets treated with mL)1 of thrombin 850 for h (in the presence or absence of the specific caspase inhibitors) were studied (Fig 5C) Data obtained in positive controls or in platelets treated for 24 h with opsonized and non-opsonized zymosan A were confirmed by western blot analysis (Fig 5D) MMP plays a key role in OPZ-mediated effects We examined the effects of an agent that is capable of specifically influencing MMP homeostasis and cell fate [12,14]: the protonophore uncoupler carbonyl cyanide fluorophenyl-hydrazone (FCCP), which is known to hinder the mitochondria hyperpolarization phenomenon at low doses [15] In particular, the ability of FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS P Matarrese et al T 90 0.5 2.1 T 24 h 104 0.4 1.9 T 30 104 104 T0 104 A Mitochondria in platelet activation 1.1 4.1 5.3 1.4 104 100 100 104 1.3 6.5 0.8 6.1 100 104 104 0.6 5.9 100 100 104 104 104 104 100 100 100 Untreated 2.1 6.7 104 100 104 104 1.3 17.3 100 104 4.4 34.9 Opsonized zymosan 100 0.6 14.3 100 100 100 104 104 100 0.5 7.4 104 104 100 100 100 100 104 104 100 100 Trypan blue 100 Zymosan 100 104 100 104 Annexin V Annexin V positive Trypan blue positive B 40 Untreated 40 Zymosan 40 30 30 20 20 20 10 10 10 T 30 T0 T 90 T 24 h 200 Events Untreated 24 h T 24 h Zymosan 24 h T0 T 30 T 90 T 24 h Minutes Opsonized zymosan 24 h 5.3 3.4 0 2.7 100 101 102 103 104 T 90 Minutes Exposure time 200 Minutes C T 30 T0 200 0 % of cells 30 Opsonized zymosan 100 101 102 103 104 100 101 102 103 104 Calcein-AM (green fluorescence) Fig OPZ induces PS externalization (A) FACS analysis after double staining with annexin V ⁄ trypan blue Dot plots from a representative FACS experiment are shown Numbers represent the percentages of annexin V-positive cells (bottom right quadrant) or annexin V ⁄ trypan blue double positive cells (upper quadrant) Note the very low percentage of cells that are positive for trypan blue (B) Results obtained from four independent experiments, reported as means and SD (C) FACS analysis after staining with calcein-AM (which is retained in the cytoplasm of live cells) of platelets treated with zymosan (central panel) or OPZ (right panel) for 24 h Untreated platelets incubated for 24 h at 37 °C (left panel) were used as the control Numbers represent the percentage of calcein-negative cells One representative experiment is shown FCCP to counteract the OPZ-induced effects in terms of ROS production, MMP alterations and PS externalization was studied (Fig 6) In our experiments, a very low dose (20 nm) of FCCP was able to hinder both the early and late events induced by OPZ In platelets pre-treated with FCCP, the increase in ROS FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS 851 Mitochondria in platelet activation P Matarrese et al Caspase 104 200 200 Zymosan 0 200 104 100 104 100 Caspase Events 200 104 100 Caspase 104 104 Opsonized zymosan 200 0 100 T 24 h 104 100 200 100 200 Caspase T 90 T0 104 200 104 100 104 100 Green fluorescence 200 100 T 24 h 0 Events 200 100 B T 90 200 T0 200 A 100 104 100 104 Green fluorescence 200 200 C Caspase activation control D LEHD-fmk 74.6 9.4 Caspase Positive control 0 104 100 104 200 Caspase activation control 200 Events 32 100 DEVD-fmk 13.4 104 100 104 20 production induced by OPZ administration for 90 was significantly reduced (Fig 6A, compare shaded gray histograms with black histograms) Fittingly, the mitochondrial membrane hyperpolarization state observed 90 after treatment with OPZ was significantly inhibited by low doses of FCCP (compare boxed areas in Fig 6B, first and third panels, with Fig 2B) The same protective effect of FCCP was observed with respect to mitochondrial membrane depolarization induced by 24 h treatment of OPZ (compare areas under the dashed line in Fig 6B, second and fourth panels, with Fig 2C) Similarly, the PS 852 32 0 69.3 100 20 Fig OPZ does not induce caspase activation Analysis of the activation state of caspases and in intact living platelets treated with zymosan (A) or opsonized zymosan (B) at various time points (C) Activation state of caspases and in a positive control represented by platelets treated for h with thrombin (1 mL)1) in medium containing mM Ca2+ Values are the percentage of cells containing these caspases in their active form Results obtained in a representative experiment are reported (D) Western blot analysis of caspase in thrombin-treated platelet (lane 2; compare with control in lane 1); untreated platelets (lane 3); platelets treated for 24 h with zymosan (lane 4) or with OPZ (lane 5) externalization observed in platelets treated for 24 h with OPZ (see Fig 4) was negligible when platelets were pre-exposed to FCCP (Fig 6C) Discussion Serum opsonized zymosan (from yeast cell walls) is known as a model phagocytic stimulus that interacts with both immunoglobulin and complement receptors, is ingested, and activates oxidative mechanisms Because OPZ engages at least two types of receptor, the signaling pathways triggered by this stimulus are FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS Zymosan M = 15 FCCP + Opsonized zymosan M = 32 Events T 90 0 Events T 90 100 101 102 103 104 100 101 102 103 104 Green fluorescence 15.2 100 104 9.7 15.5 100 104 19.3 100 16.1 100 100 104 T 24 h 104 T 90 12.3 10.1 100 104 T 24 h 104 104 T 90 9.3 100 J-aggregates FCCP + Opsonized zymosan FCCP + Zymosan B 100 104 100 complex The stimulus may be considered as an immunological stimulus, which is also able to affect human platelets by inducing an oxidative burst [10] Here we show that OPZ can trigger platelet metamorphosis [10], consisting of morphological and biochemical changes, that is typical of activation In fact, platelets rapidly changed from a discoid form to an activated shape characterized by emission of long actin-positive protrusions At the last time point (24 h), OPZ treatment was found to lead to CD47 overexpression and platelet aggregation It has been suggested that platelet activation and adhesion are associated with morphological modifications, CD47 overexpression and platelet aggregation [10,11] However, these changes were accompanied by an early and transient production of ROS, which probably serve, as in other cell systems, as signaling molecules of biological significance Activation of platelets by OPZ was associated with a transient burst in ROS, which was possibly due, at least in part, to the energy metabolism [16] Indeed, zymosan A, an activator of the alternative complement pathway, has been hypothesized to activate platelets in plasma in a complement- and fibrinogen-dependent way [9,10,17] Hence, immunological stimulation by OPZ 104 104 104 3.1 4.0 5.4 2.1 1.6 104 100 104 100 Annexin V 104 100 1.3 100 1.5 100 100 104 J-monomers Trypan blue Fig The mitochondrial membrane potential plays a key role in zymosan-mediated effects Quantitative flow cytometry evaluation of (A) ROS production, (B) MMP and (C) PS externalization in platelets pre-treated with a low dose of FCCP (20 nM) before addition of opsonized or non-opsonized zymosan A Pre-treatment with FCCP significantly reduced OPZ-induced ROS production (A, compare shaded gray histograms with black empty histograms), mitochondrial membrane hyperpolarization (compare boxed areas in B, first and third panels, with Fig 2B), mitochondrial membrane depolarization (compare areas under the dashed line in B, second and fourth panels, with Fig 2C), and PS externalization (compare numbers in C with those in Fig 4) The results shown were obtained in one experiment (representative of four) Values in (A) represent median fluorescence; those in (B) and (C) represent percentages of cells Opsonized zymosan M = 63 FCCP + Zymosan M = 21 A 200 Mitochondria in platelet activation 200 P Matarrese et al 100 7.4 104 could trigger a complex cascade of events leading to platelet remodeling and activation The main result reported here is that OPZ-stimulated platelets underwent a time-dependent hyperpolarization of mitochondria, which started early (30 min) and lasted until 90 Such mitochondrial hyperpolarization was previously observed in T cells, and was considered as an activation-associated event [12] Although the mechanism underlying this MMP increase remains unclear, it has been suggested that it could be associated with ROS signaling and could represent an early metabolic change ‘preparing’ the cell for the death process [18] On the basis of our results, we can hypothesize that mitochondrial hyperpolarization could be associated, as in lymphocytes, with platelet activation In accordance with results obtained in other cell types [14,15], the fact that the ‘stabilizing’ effect of the ‘mitochondriotropic’ drug FCCP prevented OPZ-induced mitochondrial membrane hyperpolarization as well as platelet morphological remodeling seems to suggest that the hyperpolarization state of mitochondria might represent an early transient key event sustaining platelets towards an activated phenotype, probably creating a pseudo-hypoxic redox state characterized by normoxic FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS 853 Mitochondria in platelet activation P Matarrese et al decreases of ROS and a shift from oxidative to glycolytic metabolism [19] As in other systems, low doses of FCCP could inhibit ROS signaling events that lead to the programmed mitochondrial destruction termed mitoptosis [20] In nucleated cells, mitochondria hyperpolarization occurs early after the apoptotic commitment, and is followed by MMP loss It is widely accepted that the latter could contribute to apoptosis [5] Our model system provides some further clues on this matter, and underlines the differences between nucleated and non-nucleated cells We found that PS externalization, a typical early marker of apoptosis in nucleated cells, also occurs early in OPZ-stimulated platelets, together with ROS production and mitochondria hyperpolarization Platelets, however, maintain their integrity for a long time (at least 48 h) despite MMP loss and increased PS externalization As recently reported for other stimuli, including engagement of immunoreceptors [21], OPZ induced non-apoptotic externalization of PS Furthermore, OPZ-treated platelets dis not show either caspase activation or an increase in Bcl-2 family proteins, nor cell death On this basis, we can also hypothesize that, in some immunopathological instances, the increased number of platelets could be due to a defective death of these cells (although PS-positive) rather than de novo production of these cells Conversely, other stimuli, such as collagen plus thrombin, have recently been demonstrated to induce PS externalization, a decrease in MMP, increased expression of the Bcl-2 proteins Bax and Bak, caspase activation and cell death [2,3] In addition, the physiological platelet agonist thrombin also induces Bid, Bax and Bak translocation to the mitochondria and endogenous generation of hydrogen peroxide, which stimulates cytochrome c release and activation of caspases and [22] Thus, OPZ appears to be a valuable activating agent triggering a long-term commitment to apoptosis (as also suggested by OPZ-induced PS externalization) rather than a typical apoptotic inducer The previously hypothesized role of PS externalization and its role as an adhesion factor in cell–cell interaction therefore requires reappraisal [4,23] For instance, platelet binding to dysfunctional endothelium was found to be inhibited by the phosphatidylserine-binding protein annexin V and enhanced by platelet agonists [24] Give the importance of the loss of functional integrity of platelets in the pathogenesis of cardiovascular complications often associated with diabetes and some autoimmune diseases, e.g antiphospholipid syndrome or Kawasaki disease [25,26], the results reported here indicate that OPZ could represent a prototypic 854 immunological stimulus for study of the pathogenic mechanisms of these diseases Experimental procedures Platelet isolation and treatments Blood samples were collected from healthy volunteer blood donors who had taken no drugs for at least 10 days The platelets were obtained by mixing fresh blood samples with a ⁄ 6th volume of acid ⁄ citrate dextrose (38 mm citric acid, 75 mm Na3 citrate, 135 mm glucose) as anticoagulant All the experiments were performed in platelet-rich plasma (PRP), which was prepared by centrifugation of blood samples at 150 g for 10 at room temperature Opsonized zymosan was obtained as previously reported [27] Briefly, zymosan A (Sigma Chemical Co., St Louis, MO, USA) was boiled for 20 and then washed for three times in NaCl ⁄ Pi After washing, boiled zymosan A was added to platelet-poor plasma (obtained by centrifugation of PRP at 1000 g) and incubated at 37 °C for 30 After washing three times, OPZ was ready to use Control samples were prepared using non-opsonized zymosan A Stimulation of the platelets was achieved by incubating PRP with mgỈmL)1 OPZ at 37 °C for various durations After incubation with zymosan, PRP was centrifuged at 700 g for min, and washed platelets were prepared for various analyses For experiments with FCCP (Molecular Probes, Leiden, The Netherlands), PRP was incubated for 10 with 20 nm FCCP before addition of zymosan A (both opsonized and non-opsonized) Samples treated with FCCP alone were also studied Platelets were analyzed at various time points (5, 10, 20, 30 and 90 and 6, and 24 h) after treatment with non-opsonized zymosan A or OPZ The main changes were detected after 30, 90 and 24 h: only the results obtained at these time points are shown here In addition, we also analyzed platelets treated with zymosan A (opsonized and non-opsonized) and immediately washed three times These were considered as controls to test the responsiveness of platelets immediately after interaction with zymosan A, and this time point is indicated as T0 Scanning electron microscopy Samples were collected and plated on poly-l-lysine-coated slides, and fixed with 2.5% glutaraldehyde in 0.1 m cacodylate buffer (pH 7.4) at room temperature for 20 After post-fixation in 1% OsO4 for 30 min, samples were dehydrated through a graded ethanol series, critical point-dried in CO2 and gold-coated by sputtering using a Balzers Union SCD 040 apparatus (Balzers, Weisbaden, Germany) The samples were examined using a Cambridge 360 scanning electron microscope (Leica Microsystem, Wetzlar, Germany) FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS P Matarrese et al Analytical cytology For CD47 surface detection, control and treated samples were stained with specific fluorescein isothiocyanate-conjugated monoclonal antibodies (Chemicon International Inc., Temecula, CA, USA) at °C for 30 After washing, platelets were analyzed on a flow cytometer for quantitative analysis For total CD47, F-actin, Bax and Bak detection, the samples were fixed with 0.3% paraformaldehyde in NaCl ⁄ Pi for 30 at room temperature, washed in the same buffer and permeabilized with 0.2% Triton X-100 (Sigma) in NaCl ⁄ Pi for For actin detection, samples were stained with fluorescein–phalloidin (Sigma) at 37 °C for 30 For CD47, Bax and Bak detection, polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used, followed by AlexaFluor 488-conjugated anti-rabbit IgG (Molecular Probes) After washing, all samples were analyzed for immunofluorescence by intensified video microscopy (IVM) using a Nikon Microphot microscope (Nikon, Tokyo, Japan) equipped with a CCD camera (Carl Zeiss, Oberkochen, Germany) Micrographs were captured using IAS2000 software (Delta Sistemi, Rome, Italy) Morphometric analyses On the basis of a previous study [28], quantitative evaluations of platelet aggregates were performed using DIC (Nomarski microscopy) Parallel analyses were also performed by fluorescence microscopy using anti-CD47 monoclonal antibodies In both cases, at least 20 fields were evaluated for each sample (10· objective ⁄ 0.65 numerical aperture) The samples were analyzed at various time points after treatments (T0, 30, 90 and 24 h) Mitochondrial membrane potential in living cells The mitochondrial membrane potential (MMP) of control and treated cells was studied using 5-5¢,6-6¢-tetrachloro1,1¢,3,3¢-tetraethylbenzimidazol-carbocyanine iodide (JC-1; Molecular Probes) As described previously, living cells were stained with 10 lm of JC-1 [12] Production of reactive oxygen species Cells (5 · 105) were incubated in 495 lL of Hank’s balanced salt solution, pH 7.4, with lL of DHR123 (Molecular Probes) in polypropylene test tubes for 15 at 37 °C (final concentration 10 lm) DHR123 dye freely diffuses into cells and is primarily oxidized by H2O2 in a myeloperoxidase-dependent reaction, producing green fluorescence As this oxidation does not occur in dead cells (no green fluorescence), this staining was also used to evaluate cell loss Furthermore, as DHR123 accu- Mitochondria in platelet activation mulates in mitochondria, production of ROS at the mitochondrial level can be detected [29] Cell-death assays Quantitative evaluation of apoptosis was performed by flow cytometry after double staining using fluorescein isothiocyanate-conjugated annexin V and 0.05% trypan blue for 10 at room temperature, and analyzed by fluorescenceactivated cell sorting (FACS) in the FL1 and FL3 channels to determine the percentage of dead cells The results obtained were confirmed by treating control and treated platelets with lm calcein-AM (Molecular Probes) at 37 °C for 30 Activation of caspases The activation state of caspases and was evaluated using a CaspGLOW fluorescein active caspase staining kit (MBL, Woburn, MA, USA) We also performed positive controls by using platelets treated for h with thrombin (1 mL)1) in a medium containing mm Ca2+, which has been previously reported to induce cell death and caspase activation [30] The activation state of caspase was also verified by western blot analysis using a specific antibody (Santa Cruz) Immunoreactive bands were visualized using a secondary horseradish-peroxidase-conjugated anti-rabbit IgG and a western blot detection kit, chemioluminescent system (Upstate Biotechnology, Lake Placid, NY, USA) Data analysis and statistics All samples were analyzed using a FACScan cytometer (BD Biosciences, Heidelberg, Germany) equipped with a 488 nm argon laser At least 20 000 events were acquired Statistical analyses were performed using Student’s t test or one-way variance analysis All results were verified in at least three experiments and are reported as mean ± standard deviation (SD) Only P-values < 0.01 were considered as statistically significant Acknowledgements We thank Ms Roberta Terlizzi and Dr Zaira Maroccia for their valuable technical help This study was supported by grants from the Italy–USA Collaborative Project on Rare Diseases (7qr1 ⁄ 7qr1) and the Ministero della Salute to W.M References Vanags DM, Orrenius S & Aguilar-Santelises M (1997) Alterations in Bcl-2 ⁄ Bax protein levels in platelets form FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS 855 Mitochondria in platelet activation 10 11 12 13 14 15 16 856 P Matarrese et al part of an ionomycin-induced process that resembles apoptosis Br J Haematol 99, 824–831 Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, Kelly PN, Ekert PG, Metcalf D, Roberts AW et al (2007) Programmed anuclear cell death delimits platelet life span Cell 128, 1173–1186 Dale GL & Friese P (2006) Bax activators potentiate coated-platelet formation J Thromb Haemost 4, 2664– 2669 Shcherbina A & Remold-O’Donnell E (1999) Role of caspase in a subset of human platelet activation responses Blood 93, 4222–4231 Ferri KF & Kroemer G (2001) Organelle-specific initiation of cell death pathways Nat Cell Biol 3, 255–263 Bertino AM, Qi XQ, Li J, Xia Y & Kuter DJ (2003) Apoptotic markers are increased in platelets stored at 37 °C Transfusion 43, 857–866 Leytin V, Allen DJ, Mykhaylov S, Lyubimov E & Freedman J (2006) Thrombin-triggered platelet apoptosis J Thromb Haemost 4, 2656–2663 Asghar SS & Pasch MC (2000) Therapeutic inhibition of the complement system Y2K update Front Biosci 5, 63–81 Martin SE, Breckenridge RT, Rosenfeld SI & Leddy JP (1978) Responses of human platelets to immunologic stimuli: independent roles for complement and IgG in zymosan activation J Immunol 120, 9–14 Sa YL & Huang SJ (2003) Effects of activated complements on platelets Acta Pharmacol Sin 24, 675–680 Lagadec P, Dejoux O, Ticchioni M, Cottrez F, Johansen M, Brown EJ & Bernard A (2003) Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow Blood 101, 4836–4843 Matarrese P, Gambardella L, Cassone A, Vella S, Cauda R & Malorni W (2003) Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors J Immunol 170, 6006–6015 Perl A, Gergely P Jr, Nagy G, Koncz A & Banki K (2004) Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity Trends Immunol 25, 360–367 Matsuyama S, Llopis J, Deveraux QL, Tsien RY & Reed JC (2000) Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis Nat Cell Biol 2, 318–325 Giovannini C, Matarrese P, Scazzocchio B, Sanchez M, Masella R & Malorni W (2002) Mitochondria hyperpolarization is an early event in oxidized low-density lipoprotein-induced apoptosis in Caco-2 intestinal cells FEBS Lett 523, 200–206 Del Principe D, Menichelli A, D’Arcangelo C, Strappini PM, Persiani M, Colistra C & Scarpati ML (1983) 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Opsonized-zymosan induces a respiratory burst in human blood platelets Am J Hematol 15, 353–360 Spycher MO & Nydegger UE (1995) Participation of the blood platelet in immune reactions due to plateletcomplement interaction Infusionsther Transfusionsmed 22, 36–43 Nagy G, Koncz A, Fernandez D & Perl A (2007) Nitric oxide, mitochondrial hyperpolarization, and T cell activation Free Radic Biol Med 42, 1625–1631 de Andrade PB, Casimir M & Maechler P (2004) Mitochondrial activation and the pyruvate paradox in a human cell line FEBS Lett 578, 224–228 Skulachev VP (2006) Bioenergetic aspects of apoptosis, necrosis and mitoptosis Apoptosis 11, 473–485 ´ ´ ´ Smrz D, Draberova L & Draber P (2007) Nonapoptotic phosphatidylserine externalization induced by engagement of glycosylphosphatidylinositolanchored proteins J Biol Chem 282, 10487–10497 Lopez JJ, Salido GM, Pariente JA & Rosado JA (2008) Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets J Thromb Haemost 6, 1780–1788 Zwaal RF, Comfurius P & Bevers EM (2005) Surface exposure of phosphatidylserine in pathological cells Cell Mol Life Sci 62, 971–988 Kakutani M, Masaki T & Sawamura T (2000) A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 Proc Natl Acad Sci USA 97, 360–364 Urbanus RT, Derksen RH & de Groot PG (2008) Platelets and the antiphospholipid syndrome Lupus 17, 888–894 Nigrovic LE, Nigrovic PA, Harper MB & Chiang VW (2006) Extreme thrombocytosis predicts Kawasaki disease in infants Clin Pediatr 45, 446–452 Kuo CF, Lin YS, Chuang WJ, Wu JJ & Tsao N (2008) Degradation of complement by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis Infect Immun 76, 1163– 1169 Maurer-Spurej E & Devine DV (2001) Platelet aggregation is not initiated by platelet shape change Lab Invest 81, 1517–1525 Banki K, Hutter E, Gonchoroff NJ & Perl A (1999) Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signalling J Immunol 162, 1466– 1479 Amor NB, Periente JA, Salido GM, Barteggi A & Rosado JA (2006) Thrombin-induced caspases and translocation to the cytoskeleton is independent of changes in cytosolic calcium in human platelets Blood Cells Mol Dis 43, 7978–7985 FEBS Journal 276 (2009) 845–856 ª 2009 The Authors Journal compilation ª 2009 FEBS ... and Bak, caspase activation and cell death [2,3] In addition, the physiological platelet agonist thrombin also induces Bid, Bax and Bak translocation to the mitochondria and endogenous generation... induce caspase activation Analysis of the activation state of caspases and in intact living platelets treated with zymosan (A) or opsonized zymosan (B) at various time points (C) Activation state... stimulates cytochrome c release and activation of caspases and [22] Thus, OPZ appears to be a valuable activating agent triggering a long-term commitment to apoptosis (as also suggested by OPZ-induced